Association of Circulating Chemerin Levels and Arterial Stiffness

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Korea University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Korea University
ClinicalTrials.gov Identifier:
NCT01293929
First received: February 10, 2011
Last updated: March 3, 2011
Last verified: January 2011

February 10, 2011
March 3, 2011
February 2011
March 2011   (final data collection date for primary outcome measure)
The difference of serum chemerin level between obese and non-obese groups [ Time Frame: at the time of initial enrollment (4weeks) ] [ Designated as safety issue: No ]
serum chemerin levels of all participants were by determined by an enzyme-linked immunosorbent assay (ELISA) kit (Biovender Laboratory Medicine Inc., Modrice, Czech Republic)
Same as current
Complete list of historical versions of study NCT01293929 on ClinicalTrials.gov Archive Site
The correlation of serum chemerin levels with arterial stiffness [ Time Frame: at the time of enrollment (4 weeks) ] [ Designated as safety issue: No ]
Arterial stiffness was measure using a Colin Waveform Analyser (model BP-203RPE II; Colin, Komaki, Japan). It was expressed as branchial ankle pulswe wave velocity (baPWV)
Same as current
Not Provided
Not Provided
 
Association of Circulating Chemerin Levels and Arterial Stiffness
Not Provided

Chemerin is a novel adipokine that might provide a link between chronic inflammation and obesity. Pulse wave velocity(PWV) is a useful method for examining arterial stiffness, meaning early-stage atherosclerosis. Therefore, in the present study, the investigators examined the relationship between circulating chemerin and arterial stiffness measured using PWV in obese persons.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Obese and age, gender matched non-obese group who underwent a medical health check in the Korea University Guro hospital

  • Obesity
  • Atherosclerosis
Not Provided
  • Non- obese group
  • Obese group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
120
March 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Self referred persons for visiting routine medical check in our clinic

Exclusion Criteria:

  • Malignancy
  • Severe renal or hepatic disease
Both
20 Years to 80 Years
Yes
Contact: Hye Jin Yoo 82226263045 deisy21@naver.com
Korea, Republic of
 
NCT01293929
A102065-1011-1070100
Yes
Hye Jin Yoo, Korea university
Korea University
Not Provided
Not Provided
Korea University
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP